Misuse of blood lancing devices - Notice to Hospitals — recall 24568
Health Canada — Marketed Health Products · Canada · 2009-03-24
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: Health Canada is aware of incidents where lancing devices designed for use in single patients were inappropriately used to obtain blood samples from multiple patients by health care professionals. This misuse may pose a risk of transmission of blood-borne pathogens. Lancing devices are used by individuals and health care professionals to take blood samples for glucose monitoring. There are three categories of lancing devices: disposable, reusable for single patient and reusable for multiple patients. The endcap of the lancing device is the cover protecting the needle and governing its depth of penetration into the skin. While the endcap of multiple-patient lancing devices are designed to be changed or sterilized, the endcap of single-patient lancing devices is not. Therefore the endcap of a single patient lancing device may come in contact with blood during sampling resulting in transmission of blood-borne pathogens including hepatitis B, hepatitis C and HIV if inappropriately used on multiple patients Footnote 1 Footnote 2 Footnote 3
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.